Sulodexide for Kidney Protection in Type 2 Diabetes Patients With Microalbuminuria: A Randomized Controlled Trial

Background Sulodexide, a heterogenous group of sulfated glycosaminoglycans, includes low-molecular-weight heparin (∼80% ± 8%), high-molecular-weight heparin (∼5% ± 3%), and dermatan (∼20% ± 8%), with a mean molecular weight of ∼9 kDa. The drug is absorbed orally and has no anticoagulant effect in th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of kidney diseases 2011-11, Vol.58 (5), p.729-736
Hauptverfasser:	Lewis, Edmund J., MD, Lewis, Julia B., MD, Greene, Tom, PhD, Hunsicker, Lawrence G., MD, Berl, Tomas, MD, Pohl, Marc A., MD, de Zeeuw, Dick, MD, PhD, Heerspink, Hiddo Lambers, PhD, Rohde, Richard D., BS, Atkins, Robert C., MD, Reutens, Anne T., MD, Packham, David K., MD, Raz, Itamar, MD
Format:	Artikel
Sprache:	eng
Schlagworte:	albuminuria Albuminuria - drug therapy Biological and medical sciences Diabetes Mellitus, Type 2 - complications Diabetes. Impaired glucose tolerance Diabetic Nephropathies - prevention & control diabetic nephropathy Double-Blind Method Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance Female glycosaminoglycans Glycosaminoglycans - therapeutic use Humans Kidney Diseases - prevention & control Kidneys Male Medical sciences microalbuminuria Middle Aged Nephrology Nephrology. Urinary tract diseases Sulodexide Urinary system involvement in other diseases. Miscellaneous
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!